↓ Skip to main content

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, March 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#36 of 1,159)
  • High Attention Score compared to outputs of the same age (97th percentile)

Mentioned by

news
15 news outlets
twitter
19 tweeters

Citations

dimensions_citation
133 Dimensions

Readers on

mendeley
219 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
Published in
Alzheimer's Research & Therapy, March 2020
DOI 10.1186/s13195-020-00588-4
Pubmed ID
Authors

Martí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, Kaj Blennow, Anthony Caggiano, Steven T. DeKosky, Howard Fillit, John E. Harrison, Lon S. Schneider, Phillip Scheltens, Willem de Haan, Michael Grundman, Christopher H. van Dyck, Nicholas J. Izzo, Susan M. Catalano

Twitter Demographics

The data shown below were collected from the profiles of 19 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 219 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 219 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 44 20%
Researcher 31 14%
Student > Bachelor 31 14%
Student > Master 22 10%
Student > Doctoral Student 8 4%
Other 30 14%
Unknown 53 24%
Readers by discipline Count As %
Neuroscience 58 26%
Biochemistry, Genetics and Molecular Biology 27 12%
Medicine and Dentistry 18 8%
Agricultural and Biological Sciences 9 4%
Unspecified 6 3%
Other 38 17%
Unknown 63 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 113. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2020.
All research outputs
#294,801
of 22,113,391 outputs
Outputs from Alzheimer's Research & Therapy
#36
of 1,159 outputs
Outputs of similar age
#7,740
of 287,085 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#1
of 1 outputs
Altmetric has tracked 22,113,391 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,159 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,085 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them